Hi duckdog,
Therapure isn't something new around the corner. as it's was formed on the Hemososl ashes years ago.
As you mentionned, the technology used was acquiered by a danish company.
However, the same technology was acquired by Cangene in 2009, (see my link below) and obviously, Cangene just wasn't able to make money out of it, as they let go the rights after.
So far, Therapure mentionned a list of proteins that are used as therapeutic. However, they are not showing they can effectivly extract those proteins, and how much.
Therapure is looking for partnership, but for now, except a few CMO contracts, they didn't show a lot of things in proteins extraction.
So, can they be in competition with PLI, not really for the moment. A part being a CMO, they seems far away of doing what PLI is doing, which is extract on a commercial scale proteins, and turn them into therapeutic.
I really think they at least 10-15 years behind Prometic in term of development. Maybe one day, we will see them in a clinical trial for a plasma protein prduct. But by then, PLI will be very well positionned on the market.
For me, there's nothing to worried about.....
And good news, the government invested money in that company. Have you ever seen a governement investment that went good? :-)
https://www.nbgipe.com/ventures/news/news-article/items/upfront-chromatography-licenses-use-of-eba-technology-to-cangene/